Investor Overview

TomoTherapy Incorporated has developed, manufactures and sells the Hi·Art® treatment system, one of the most advanced and versatile radiation therapy systems available for the treatment of a wide variety of cancers.

In use at hospitals and cancer centers in North America, Europe and Asia, the Hi·Art treatment system delivers image-guided, intensity-modulated radiation to kill cancer cells while reducing radiation exposure to surrounding healthy tissue.
More

Active Webcasts
Recent NewsRSS RSS Feeds | More
DateTitle 
08/26/08TomoTherapy Receives FDA 510(k) Clearance for TomoDirect(TM) Radiotherapy Technology
Innovative New Delivery Mode Boosts Efficiency and Versatility of Hi-Art(R) Treatment System MADISON, Wis.--(BUSINESS WIRE)--Aug. 26, 2008--TomoTherapy Incorporated (NASDAQ: TOMO) today announced that it has received FDA 510(k) clearance for its TomoDirect(TM) radiation therapy technology. TomoDirect is an innovative new discrete-angle, sliding-beam delivery mode for the Hi-Art(R) treatment system. With this capability, clinicians gain an efficient complement to helical TomoTherap... 
Printer Friendly Version
08/25/08TomoTherapy Announces Management Transitions
Hathaway to Retire in March 2009; Klein Resigns; Company Names Guse Interim Vice President of Global Sales MADISON, Wis.--(BUSINESS WIRE)--Aug. 25, 2008--TomoTherapy Incorporated (NASDAQ: TOMO), producer of the Hi-Art(R) treatment system for advanced radiation therapy, announced today that Stephen C. Hathaway, CFO, plans to retire when his employment contract expires on March 31, 2009. Hathaway announced his intention at an early date to ensure a smooth transition of TomoTherapy's... 
Printer Friendly Version
08/19/08TomoTherapy to Host Analyst and Investor Presentation at 2008 ASTRO Meeting in Boston
MADISON, Wis.--(BUSINESS WIRE)--Aug. 19, 2008--TomoTherapy Incorporated (NASDAQ: TOMO), producer of the Hi-Art(R) treatment system for advanced radiation therapy, announced today that it will host an analyst and investor presentation in conjunction with the 50th annual ASTRO (American Society for Therapeutic Radiology and Oncology) meeting on Monday, Sept. 22, 2008, at 7:45 a.m. ET. Analysts and institutional investors are invited to register for this event by visiting: http://pu... 
Printer Friendly Version
08/07/08TomoTherapy to Introduce TomoDirect(TM) at ESTRO, ASTRO Annual Meetings
New, Discrete-Angle Radiation Delivery Mode Extends Hi-Art(R) System Capabilities, Offering Faster Planning and Treatment for a Wide Range of Cancer Cases MADISON, Wis.--(BUSINESS WIRE)--Aug. 7, 2008--TomoTherapy Incorporated (NASDAQ: TOMO) today announced that it will introduce the TomoDirect(TM) discrete-angle delivery mode(1) for the TomoTherapy(R) Hi-Art(R) treatment system at two upcoming radiation oncology conferences. This innovative new technology allows Hi-Art system user... 
Printer Friendly Version
Upcoming EventsMore
DateTitle
09/22/08 7:45 a.m. ET
TomoTherapy Incorporated Analyst and Investor Presentation at 2008 ASTRO Meeting in Boston
Featured ReportMore
Download Documentation 2007 Annual Report

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Printer Friendly Version Print Page | E-mail this page E-mail Page | RSS RSS Feeds | E-mail Alerts E-mail Alerts | Download Financial Tear Sheet Tear Sheet